6 months after COVID-19 hit, one trend has emerged as a dominant theme: making virtual clinical trials a reality. Catch up on the recent survey data.
If you’re going to start a clinical trial in the post-COVID area, a virtual investigator meeting needs to be in your plans. Here’s how to do it.
Interview: Start-Up Phase is a Prime Target for Virtual Activities in Clinical Trials, So Let’s Adapt
Before 2020 “virtual clinical trials” was just a buzzword. Now we’re forced to adapt. But what challenges – and opportunities – are ahead?
As COVID-19 continues to impact us, principle investigator meetings are off the table. Or are they? Yes, you can pull off an effective, virtual investigator meeting for your clinical trial. Here’s how to make sure you do.
Implementing clinical trial readiness enables you to confidently predict who will succeed in conducting your clinical trial – and who needs more preparation.
Until the recent changes forced upon clinical research by COVID-19, we have relied heavily on in-person activities. But COVID has accelerated our adoption of digital tools. Is this the dawn of a more digital clinical trial environment? Take a look at these 5 areas that can benefit most from digital transformation.
You’re using the clinical trial site selection checklist you’ve always used, but you’re still struggling with the same delays, site problems, and retraining you see in every trial. Why? It’s time to adjust the way you measure your sites for selection.